Amidated forms of the peptide hormone gastrin act via the cholecystokinin-2 receptor to stimulate gastric acid secretion, whereas non-amidated forms stimulate colonic mucosal proliferation via a novel, as yet uncharacterised, receptor. Nuclear magnetic resonance (NMR) and fluorescence spectroscopic studies have revealed that glycineextended gastrin17 bound two ferric ions, and that ferric ion binding was essential for biological activity. We have therefore investigated the role of ferric ions in the biological activity of amidated gastrin17. As with glycineextended gastrin17, fluorescence quenching experiments indicated that Glu7 Ala and Glu8,9 Ala mutants of amidated gastrin17 each bound only one ferric ion. The affinity of the mutant peptides for the cholecystokinin-2 receptor on transfected COS-7 cells or on Tlymphoblastoid Jurkat cells, and their potency in stimulation of proliferation in Jurkat cells and inositol phosphate production in transfected COS-7 cells, were similar to the values obtained for amidated gastrin17. In addition, the iron chelator desferrioxamine did not significantly inhibit either binding of amidated gastrin17 to the cholecystokinin-2 receptor, or stimulation of inositol phosphate production by amidated gastrin17 in transfected COS-7 cells. We conclude that, in contrast to glycineextended gastrin17, binding of ferric ions is not essential for the biological activity of amidated gastrin17. Our results support the concept of distinct modes of action for amidated and non-amidated gastrins, and raise the possibility of developing selective antagonists of the actions of non-amidated and amidated gastrins.
Introduction
Many peptide hormones are synthesised as precursors that undergo proteolytic cleavage and post-translational processing to form the mature amidated hormone (Prigge et al. 2000) . Although C-terminal amidation was thought to be essential for the bioactivity of most peptide hormones, there are an increasing number of examples where a glycine-extended intermediate is also bioactive. Examples include secretin-gly, gastrin releasing peptide (GRP)-gly, glucagon-like peptide (GLP)-1-gly and substance P (Wettergren et al. 1998 , Abou-Mohamed et al. 2000 , Oiry et al. 2000 , Solomon et al. 2001 . However, these glycine-extended forms either interact with the same receptor type as the amidated form or are converted to the mature form close to the site of action.
Gastrin is synthesised as a precursor (progastrin) that is processed via a glycine-extended form (Ggly) to the amidated hormone (Gamide) (Dockray 1999) . In addition to regulating gastric acid secretion, the peptide hormone gastrin stimulates the growth of the gastric mucosa in vivo and various gastrointestinal cell lines in vitro (Baldwin 1995a . Recently, several groups have also described a significant effect of gastrins on cell migration (De Hauwer et al. 1998 , Hollande et al. 2001 , Kermorgant & Lehy 2001 , Bierkamp et al. 2002 , Kirton et al. 2002 , Wroblewski et al. 2002 . On the basis of binding and molecular biological studies, two high-affinity receptors for gastrin and the related peptide hormone cholecystokinin (CCK) have been characterised and cloned (Ito et al. 1993 , Lee et al. 1993 , Ulrich et al. 1993 . Although the CCK-1 and CCK-2 receptors both belong to the family of G-coupled receptors and share 50% sequence homology, they can be distinguished using selective agonists and antagonists (Noble et al. 1999) .
In the last decade progastrin processing intermediates such as Ggly and progastrin itself have been found by several laboratories to be biologically active (Seva et al.1994 , Hollande et al. 1997 , Baldwin et al. 2001b , Hollande et al. 2001 . For instance Ggly and progastrin stimulate colonic proliferation and accelerate the development of colorectal cancers in transgenic mouse models (Singh et al. 2000 , Koh et al. 2001 , modulate migration in gastrointestinal cell lines (Hollande et al. 2001 , Kermorgant & Lehy 2001 , and are elevated in patients with colorectal cancer (Ciccotosto et al. 1995) . These observations demonstrate important physiological and pathological roles for non-amidated forms of gastrin. Although a new gastrin binding site which bound both amidated and glycineextended gastrins with low affinity has been described (Baldwin 1995b) , no high-affinity Ggly receptor has yet been cloned.
We recently demonstrated by fluorescence quenching that gastrins bind two ferric ions with high affinity in aqueous solution (Baldwin et al. 2001a ). The nuclear magnetic resonance (NMR) spectral changes following the addition of one or two equivalents of ferric ions to Ggly solutions indicated that Glu7 acts as a ligand at the first ferric ion binding site, and that Glu8 and Glu9 act as ligands at the second ferric ion binding site (Pannequin et al. 2002) . The ligand identification was confirmed by monitoring the fluorescence changes on addition of ferric ions to Ggly mutants with substitutions of alanine for one or more of the glutamates. The complete lack of activity in both proliferation and migration assays of a Ggly mutant in which Glu7 was replaced by Ala (GglyE7A), and the inhibition of Ggly activity by the iron chelator desferrioxamine (DFO), were consistent with the hypothesis that ferric ion binding is essential for biological activity. The significant (60%) reduction in the ability of Gamide to stimulate proliferation in IMGE gastric cells incubated for 72 h in the presence of DFO suggested that binding of ferric ions might also contribute to the activity of amidated gastrins (Pannequin et al. 2002) .
The aim of the present work was to define the role of ferric ion binding in the biological activity of Gamide. The involvement of Glu7, Glu8 and Glu9 in ferric ion binding to Gamide was first determined by fluorescence spectroscopy. The affinities for the CCK-2 receptor of Gamide, and Gamide mutants with substitutions of alanine for one or more of the glutamates (Fig. 1) , were then compared. The abilities of the mutant peptides to stimulate both proliferation in T-lymphoblastoid Jurkat cells which express the CCK-2 receptor, and inositol phosphate production in COS-7 cells transiently transfected with the CCK-2 receptor, were also investigated. We report that Glu7, Glu8 and Glu9 of Gamide are critical for binding ferric ions. However, the observation that the mutant peptides were as active as Gamide in all assays indicates that ferric ion binding is not required for the biological activity of amidated gastrins.
Materials and Methods

Chemicals and cell lines
Gamide and Gamide mutants were synthesised by Bachem (Bubendorf, Switzerland) and Auspep (Melbourne, Australia) respectively. Peptide concentrations were calculated from their absorbance at 280 nm as described previously (Baldwin et al. 2001a) .
COS-7 cells were grown in 175 cm 2 culture flasks in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum (FBS), 100 U/ml penicillin and 100 µg/ml streptomycin at 37 C .
The T-lymphoblastoid cell line Jurkat (Dornand et al. 1995) (kindly provided by Dr C Oiry, Université de Montpellier I, Montpellier, France) was grown at 37 C in RPMI 1640 medium containing 8% FBS, 100 U/ml penicillin and 100 µg/ml streptomycin.
Fluorescence spectroscopy
The tryptophan fluorescence of peptide solutions was measured in 3 ml quartz cuvettes thermostatted at 25 C, with a Spex Fluorolog-2 spectrofluorimeter (Spex Industries, Edison, NJ, USA), with the excitation and emission wavelengths set at 290 and 345 nm respectively (Baldwin et al. 2001a) . The quenching of tryptophan fluorescence induced by the binding of metal ions was used to calculate the fraction of binding sites occupied, f a :
where y is the fluorescence signal at a given concentration of metal ions, and y b and y f are the signals when the binding sites are fully occupied and unoccupied respectively (Baldwin et al. 2001a) . The stoichiometry, p, and apparent dissociation constant, K d , were then obtained, using the program Sigmaplot (Jandel Scientific, San Rafael, CA, USA), from the intercept and slope of a linear regression of the data transformed in terms of the equation
where C s is the total concentration of metal ions and C a is the total concentration of amidated gastrin17 (Winzor & Sawyer 1995) .
Transient transfection of COS-7 cells
COS-7 cells were transiently transfected by the diethylaminoethyl (DEAE)-dextran method as described The structures of alanine-substituted peptides derived from amidated gastrin17 (Gamide) are shown. Amino acids are shown in the one letter code, and Z represents a pyroglutamate residue. The -(Glu) 5 -sequence is highlighted in bold. In Gamide mutants alanine residues, which replaced some or all of the original glutamate residues, are underlined. Amidated gastrin17 corresponds to residues 55-71 of progastrin 1-80 . previously (Mantamadiotis & Baldwin 1994) . One day before transfection, 7 10 5 COS-7 cells were seeded into 10 cm plates in DMEM containing 10% FBS and antibiotics, and grown in 5% CO 2 such that on the day of transfection the cells were 60% confluent. On the day of transfection, a DNA/DEAE-dextran solution was prepared by dropwise addition of 0·5 ml 2 mg/ml DEAEdextran in PBS to 0·5 ml 0·1% glucose in PBS containing 0·5-2·5 µg/ml pRFE Neo plasmid DNA encoding the human CCK-2 receptor (Kennedy et al. 1995) . The medium was aspirated and the cells were washed twice with PBS containing 0·1% glucose, and gently rocked at 37 C for 20 min in the DNA/DEAE-dextran solution. The solution was then aspirated carefully, and replaced with 10 ml 100 µM chloroquine, and the cells were incubated at 37 C for 3 h. After incubation, the solution was aspirated and the cells were washed twice with serum-free DMEM and grown overnight in DMEM containing 10% FBS and antibiotics. On the next day, the transfected cells were detached with 0·25% trypsin/0·02% EDTA, re-plated onto a 24-well dish (25 000-100 000 cells/well) and grown for a further 24 h prior to the receptor binding or inositol phosphate assay.
CCK-2 receptor binding
Binding of Gamide, GamideE7A, and GamideE8,9A to the human CCK-2 receptor on transfected COS-7 cells was measured in triplicate by competition for 125 I-Bolton and Hunter-labelled CCK-8 ( 125 I-BH-CCK 8 ) binding (Kopin et al. 1992) . Transfected COS-7 cells were grown to 60-70% confluence as described above, washed once Figure 2 Glutamate residue 7 acts as a metal ion ligand. The quenching by ferric ions of the tryptophan fluorescence (A) of Gamide-derived peptides with single or double alanine substitutions was measured as described in Materials and Methods. The peptides were as follows: Gamide (•), GamideE7A (), GglyE8,9A (). The buffer was 10 mM sodium acetate, pH 4·0, containing 100 mM NaCl and 0·005% Tween 20. Values of the stoichiometry and the apparent dissociation constant were obtained from the intercept and slope respectively of linear transformations of the data for peptides with single (B) or double (C) alanine substitutions by least squares fitting with the program Sigmastat. The values of at least three independent experiments were combined to obtain the mean values presented in Table 1 . Substitution of the glutamate(s) at position 7, or at positions 8 and 9, of Gamide resulted in a reduction of one in the number of bound ferric ions. Table 1 Stoichiometry and affinity of ferric ion binding by amidated gastrin17 and related peptides. The tryptophan fluorescence of amidated gastrin17 and related peptides was measured in the presence of increasing concentrations of ferric ions at pH 4·0 (Baldwin et al. 2001a) . Values of the stoichiometry and the apparent dissociation constant (K d ) were obtained from linear transformations of the data presented in Fig. 2A by least squares fitting. Values from the indicated number of independent experiments were combined to obtain the mean values ( S.E.) presented below. The values previously reported (Pannequin et al. 2002) for Ggly are included for comparison
with PBS, and then incubated for 1 h at 37 C in 500 µl DMEM containing 0·1% BSA and 125 I-BH-CCK-8 (100 000 c.p.m., 14·5 fmol, Amersham), in the presence and absence of peptide competitor. Cells were then washed twice with PBS containing 2% BSA and lysed with 1 ml 0·1 M NaOH. Lysates were counted in acounter (LKB-Wallac, Turku, Finland) at 77% efficiency.
Binding of Gamide, GamideE7A and GamideE8,9A to the human CCK-2 receptor on Jurkat cells was measured in triplicate by competition for 125 I-BH-CCK 8 binding as described above. Jurkat cells were grown as described above, harvested by centrifugation at 1200 g for 5 min, and re-suspended in PBS containing 0·2% BSA. Cells (1 10 6 cells/400 µl per tube) were incubated with 125 I-BH-CCK 8 in the presence or absence of peptide competitor for 1 h at 37 C. The binding reaction was terminated by addition of 2 ml/tube of ice-cold PBS containing 2% BSA followed by centrifugation at 3000 g for 10 min. The pellets were counted in a -counter.
Estimates of the concentration giving 50% inhibition (IC 50 ), and of the levels of 125 I-BH-CCK 8 bound in the absence of competitor, were obtained by nonlinear regression with Sigmaplot to the equation
where y is the binding expressed as a percentage of the value a observed in the absence of peptide competitor, x is the concentration of peptide competitor, and b is the IC 50 value.
Proliferation experiments
Cell proliferation was measured by counting. Jurkat cells were grown in RPMI 1640 without FBS for 24 h and subsequently seeded into 96-well plates at a concentration of 5 10 4 cells/ 200 µl, in media containing 2% FBS. At the same time the test compounds were added at 100 nM concentration. After incubation for 48 h at 37 C the cells were stained with trypan blue (0·4%), and live cells were counted using a haemocytometer.
Measurement of inositol phosphate production
Intracellular inositol phosphate production was determined as described previously (Qian et al. 1995) . CCK-2 receptor-transfected COS-7 cells (10 5 cells/ml) were plated in 24-multiwell culture plates in DMEM supplemented with 10% FBS, 200 U/ml penicillin and 200 mg/ml streptomycin; 24 h later, cells were incubated overnight at 37 C with 5% CO 2 in 0·5 ml DMEM supplemented with antibiotics and myo-[2-
H]inositol
Figure 3 Glu7, Glu8 and Glu9 are not essential for binding of Gamide to the CCK-2 receptor on transfected COS-7 cells. The ability of increasing concentrations of Gamide (A), GamideE7A (B) and Gamide E8,9A (C) to compete with 125 I-BH-CCK 8 (150 pM, 100 000 c.p.m.) for binding to the human CCK-2 receptor on transiently transfected COS-7 cells was measured as described in Materials and Methods. Points are the means S.E. of triplicates, expressed as a percentage of the value obtained in the absence of peptide competitor. The lines of best fit were obtained by nonlinear regression to a single site model with the program Sigmaplot. The values for IC 50 and for the predicted ordinate intercept were as follows: Gamide, 29 nM, 86·1%; GamideE7A, 25 nM, 91·6%; GamideE8,9A, 58 nM, 91·0%. These values were combined with the data from at least two other experiments to obtain the mean values presented in Table 2 . Substitution of the glutamates at position 7, or at positions 8 and 9, of Gamide did not significantly reduce the affinity of binding to the human CCK-2 receptor on transiently transfected COS-7 cells.
(2·5 µCi/well). Cells were then washed with pre-warmed DMEM and incubated (30 min, 37 C) with DMEM supplemented with 20 mM LiCl. Loaded cells were then washed in 1 ml inositol phosphate buffer (135 mM NaCl, 20 mM HEPES, 2 mM CaCl 2 , 1·2 mM MgSO 4 , 1 mM EGTA, 10 mM LiCl, 0·5% BSA, pH 7·45) and incubated with or without agonist in 0·5 ml of the same buffer. After 1 h at 37 C, the reaction was stopped by removing the incubation medium and adding 1 ml ethanol/HCl (2000:1, v/v). The solution was applied to a column containing 0·8 ml Dowex AG-1-X8 anion exchange resin, which had been previously equilibrated with Milli-Q water. The columns were washed with 4 ml Milli-Q water, followed by 4 ml 40 mM ammonium formate, and inositol phosphates were eluted with 4 ml 1 M ammonium formate. The radioactivity of each eluate was determined in a Packard Tri-Carb 2100TR liquid scintillation analyser after addition of complete phase-combining solution (Amersham). For the positive control, transfected COS-7 cells were incubated with AlF 4 prepared by combining 30 mM NaF and 10 µM AlCl 3 under the same experimental conditions.
Statistics
Results are expressed as the means S.E. Data were analysed by one-way ANOVA. If there was a statistically significant difference in the data set, individual values were compared with the control by t-test with Bonferroni correction for multiple analyses. Differences with P values of,0·05 were considered significant.
Results
We have reported previously that both Ggly and Gamide bound two ferric ions in aqueous solution at pH 4·0, with an apparent K d of 0·6 µM (Baldwin et al. 2001a) . Investigation of the effect of ferric ions on the Ggly NMR spectrum indicated that Glu7 was acting as one of the ligands for the first ferric ion binding site, and that Glu8 and Glu9 were acting as ligands for the second ferric ion binding site (Pannequin et al. 2002) . This observation was confirmed by examination of the ability of ferric ions to quench the fluorescence of mutant Ggly peptides in which some or all of the glutamates had been replaced by alanines. For example, replacement of Glu7 with Ala reduced the stoichiometry of ferric ion binding by 1 without greatly changing the apparent affinity (Pannequin et al. 2002) .
Definition of ferric ion ligands
In order to confirm that Glu7, Glu8 and Glu9 were also involved in ferric ion binding to Gamide, we first investigated the ability of ferric ions to quench the fluorescence of mutant Gamide peptides in which Glu7, or Glu8 and Glu9, had been replaced by alanines. A pH value of 4·0 was selected for these experiments to permit direct comparison with previous data on Ggly (Baldwin et al. 2001a ) and mutant Ggly peptides (Pannequin et al. 2002) . This value was originally chosen to avoid problems with the precipitation of ferric hydroxides at pH.4·0 (Baldwin et al. 2001a) . As with Ggly, replacement of Glu7 with Ala reduced the stoichiometry of ferric ion binding by 1 without greatly changing the apparent affinity (Fig. 2 , Table 1 ). The importance of Glu8 and Glu9 in binding the second ferric ion was confirmed by the similar reduction in stoichiometry observed with a mutant Gamide peptide in which Glu8 and Glu9 had both been replaced by alanines (Fig. 2, Table 1 ).
Role of glutamates in CCK-2 receptor binding
In order to determine the importance of Glu7, Glu8 and Glu9 in the binding of Gamide to the CCK-2 receptor, the two mutant peptides GamideE7A and Gamide E8,9A were tested for their ability to bind to COS-7 cells transiently transfected with CCK-2 receptor cDNA. Both Table 2 Affinity of amidated gastrin17 and related peptides for the CCK-2 receptor. Binding of 125 I-BH-CCK 8 to COS-7 cells transiently transfected with the CCK-2 receptor, or to Jurkat cells, was measured in displacement experiments with increasing concentrations of Gamide or related peptides as described in Fig. 3 legend. Values of the percentage maximum binding in the absence of competitor and of the IC 50 were obtained from the data presented in Fig. 3 peptides retained the ability to compete with 125 I-BH-CCK 8 , and their affinities for the CCK-2 receptor were not significantly lower than the affinity of Gamide (Fig. 3, Table 2 ). Because the affinity of Gamide 50 and for the predicted ordinate intercept were as follows: Gamide, 1·8 nM, 98·2%; GamideE7A, 3·0 nM, 90·6%; GamideE8,9A, 3·8 nM, 113·6%. These values were combined with the data from at least two other experiments to obtain the mean values presented in Table 2 . Substitution of the glutamates at position 7, or at positions 8 and 9, of Gamide significantly reduced the affinity of binding to the human CCK-2 receptor on Jurkat cells.
Figure 5
Glu7, Glu8 and Glu9 are not essential for Gamide-induced biological activity. The effect of 100 nM Gamide, GamideE7A, or GamideE8,9A on proliferation of Jurkat cells (A), or of 10 nM Gamide, GamideE7A, or GamideE8,9A on inositol phosphate production (B) in COS-7 cells transiently transfected with the human CCK-2 receptor, was measured as described in Materials and Methods. (A) Means S.E. from three independent experiments, each performed in triplicate. (B) Means S.E. of triplicates, and similar results were obtained in three independent experiments. All data are expressed as a percentage of the value obtained in the absence of stimulation. The effect of 10% FBS (A) or 10 M AlF 4 (AlF) (B) was determined as a positive control. Statistical significance relative to the untreated control (**, P,0·01; ***, P,0·001) was assessed by one-way ANOVA, followed by t-test with Bonferroni correction. No significant difference was observed in the extent of stimulation by Gamide, GamideE7A or GamideE8,9A.
(IC 50 =27 7 nM; Table 2) was itself lower than values previously reported for COS-7 cells (IC 50 =0·94 nM, Ulrich et al. 1993 ; IC 50 =6·4 nM, Kopin et al. 1992) , the same experiments were repeated with the T-lymphoblastoid cell line Jurkat, which has previously been demonstrated to express CCK-2 receptors (IC 50 =1·05 nM, Dornand et al. 1995) . The affinities of all peptides for the CCK-2 receptor on Jurkat cells were approximately 10-to 20-fold higher than for the receptor on COS-7 cells. In this case the affinities of the mutant peptides for the CCK-2 receptor were slightly but significantly lower than the affinity of Gamide for the receptor (Fig. 4, Table 2 ).
Role of glutamates in biological activity
We then investigated the role of the individual glutamates in biological activity. The effects of the mutants GamideE7A and GamideE8,9A (see Fig. 1 for sequences) on proliferation of Jurkat cells were compared (Fig. 5A) . The effects of the mutants GamideE7A and GamideE8,9A on inositol phosphate production in COS-7 cells transiently transfected with the CCK-2 receptor were also compared (Fig. 5B) . The observation that GamideE7A and GamideE8,9A were both as active as Gamide indicated that Glu7 did not play a critical role in Gamide-stimulated inositol phosphate production.
Role of ferric ions in CCK-2 receptor binding and biological activity
In order to confirm that the binding of ferric ions to Glu7, Glu8 and Glu9 did not affect the binding of Gamide to the CCK-2 receptor, the ability of the iron chelating agent DFO to interfere with the binding of 125 I-BH-CCK 8 to the CCK-2 receptor was investigated. No significant difference in the IC 50 value for Gamide binding to the CCK-2 receptor in transiently transfected COS cells . These values were combined with the data from at least two other experiments to obtain the mean values presented in Table 3 . The iron chelator DFO did not significantly reduce the affinity of the human CCK-2 receptor on transiently transfected COS-7 cells or on Jurkat cells for Gamide. (C) The effect of 10 M AlF 4 (AlF) or 10 nM Gamide in the presence and absence of 1 M DFO, on inositol phosphate production in COS-7 cells transiently transfected with the human CCK-2 receptor was measured as described in Fig. 5 legend. Statistical significance relative to the untreated control (**, P,0·01; ***, P,0·001) was assessed by one-way analysis of variance, followed by t-test with Bonferroni correction. No significant difference was observed in the extent of stimulation by Gamide in the presence and absence of the iron chelator DFO. Similar results were obtained in three independent experiments. (Fig. 6A ) or in Jurkat cells (Fig. 6B) was observed in the presence and absence of DFO (Table 3) .
We also investigated the effect of the iron chelator DFO on the biological activity of gastrins. DFO had no effect on Gamide-stimulated inositol phosphate production in COS-7 cells transiently transfected with the CCK-2 receptor (Fig. 6C) . We conclude that binding of ferric ions to Glu7, Glu8 and Glu9 is not essential for the biological activity of Gamide.
Discussion
We have previously demonstrated that Ggly binds two ferric ions selectively and with high affinity (Baldwin et al. 2001a) . The first and second site ferric ion ligands were identified by NMR and fluorescence spectroscopy as Glu7, and Glu8 and Glu9 respectively (Pannequin et al. 2002) . Binding of ferric ions was shown to be essential for the effects of Ggly on both cell proliferation and migration (Pannequin et al. 2002) . The first aim of the work presented here was to locate the ferric ion binding sites within the Gamide sequence by fluorescence spectroscopy of mutant peptides in which some or all of the glutamates had been replaced by alanines. The second aim was to determine the role of ferric ion binding in the biological effects of Gamide. The results presented in this paper demonstrate for the first time that ferric ions bind to Glu7, Glu8 and Glu9 of Gamide, but reveal that in contrast to Ggly, ferric ion binding is not essential for the biological activity of Gamide.
Replacement of Glu7 with Ala reduced the stoichiometry of ferric ion binding from the value of 1·6 observed with Gamide to 0·9, without changing the apparent affinity (Table 1 ). The importance of glutamates 8 and 9 in binding the second ferric ion was confirmed by the similar reduction in stoichiometry observed with a peptide in which glutamates 8 and 9 had both been replaced by alanines. Sequence comparisons of gastrins across eight mammalian species are also consistent with an important role for Glu7, Glu8 and Glu9, since these three residues are strictly conserved with the exception of equine gastrin, which has Lys instead of Glu7 (Moore et al. 1997) . In contrast, Glu10 is unlikely to play a functional role since in four species it is replaced by Ala (Moore et al. 1997) .
Progastrin 6-80 also binds two ferric ions with similar affinity to Gamide and Ggly (Baldwin 2004 (Peggion et al. 1983) , the inability of Ca 2+ ions to compete with 59 Fe 3+ for the progastrin binding site was consistent with the failure to detect high-affinity Ca 2+ binding to Gamide in aqueous solution (Torda et al. 1985) . The high-affinity Ca 2+ binding site in progastrin (Baldwin et al. 2001b ) is presumably formed wholly or in part from residues 6-54 and 73-80, which are removed during processing to Gamide.
Mutation of Glu7, or Glu8 and Glu9, to Ala slightly decreased the affinity of Gamide for the CCK-2 receptor ( Table 2 ). The ratio of IC 50 GamideE7A/IC 50 Gamide was 1·4 for transfected COS-7 cells and 2·4 for T-lymphoblastoid Jurkat cells, but the difference was significant in the latter case only. Similarly the ratio of IC 50 GamideE8,9A/IC 50 Gamide was 4·1 for transfected COS-7 cells and 2·2 for T-lymphoblastoid Jurkat cells, and the difference was significant in the latter case only. We conclude that Glu7, Glu8 and Glu9 are not essential for binding of Gamide to the CCK-2 receptor. Furthermore, since Glu7, Glu8 and Glu9 have been defined as the ligands for ferric ion binding to Gamide, we conclude that binding of ferric ions is not essential for recognition of Gamide by the CCK-2 receptor. The 10-to 40-fold difference in the affinities measured in COS-7 cells and Jurkat cells may perhaps be explained by the greater amounts of CCK-2 receptor expressed in COS-7 cells. For example, there may be insufficient amounts of G protein, Table 3 Effect of DFO on the affinity of amidated gastrin17 for the CCK-2 receptor. Binding of 125 I-BH-CCK 8 to COS-7 cells transiently transfected with the CCK-2 receptor, or to Jurkat cells, was measured in displacement experiments with increasing concentrations of Gamide in the presence and absence of 1 M DFO as described in Fig. 6 legend. For COS-7 cells, values ( S.E.) of the percentage maximum binding in the absence of competitor and of the IC 50 were obtained from the data presented in Fig. 6 or other intracellular protein coupled to the CCK-2 receptor, to convert all the CCK-2 receptor to the higher affinity form.
Comparison of the ability of Gamide mutants, in which one or more of the glutamates were replaced by alanine, to stimulate proliferation or inositol phosphate production revealed that Glu7, Glu8 and Glu9 were not essential for biological activity. In contrast, comparison of Ggly mutants, in which one or more of the glutamates were replaced by alanine, had previously demonstrated that Glu7 was essential for proliferation (Pannequin et al. 2002) . Our results are consistent with previous data on the physiological properties of a series of synthetic peptides structurally related to Gamide (Tracy & Gregory 1964) , which indicated that only the C-terminal tetrapeptide Trp-Met-Asp-Phe-NH 2 was required for a range of physiological effects. These results have been confirmed in binding experiments with Gamide fragments and the cloned CCK-2 receptor (Kopin et al. 1992 , Ito et al. 1993 . However, residues N-terminal to the tetrapeptide must contribute to the binding of Gamide to the CCK-2 receptor, since both potency in bioassays and affinity for the CCK-2 receptor increased with chain length. The observation that pentagastrin (tert-butoxycarbonyl--AlaTrp-Met-Asp-Phe-amide) is as potent as Gamide in vivo (Morley et al. 1965) , suggests that the additional tertbutoxycarbonyl--Ala group of pentagastrin makes a contribution to the binding energy approximately equal to the contribution of the polyglutamate ferric ion binding region. Both contributions could arise from independent binding to different regions of the receptor. In the case of pentagastrin that contribution would be independent of ferric ions, but in the case of Gamide it could be either iron dependent or iron independent. The possible contribution of ferric ions had not been investigated prior to our work.
The results of experiments with the iron chelator DFO are consistent with the bioactivity and binding data for Gamide derivatives described in the previous paragraph. Thus, DFO had no effect on the affinity of Gamide for the CCK-2 receptor expressed on COS-7 cells (Fig. 6A) or on Jurkat cells (Fig. 6B) , or on the ability of Gamide to stimulate inositol phosphate production in COS-7 cells (Fig. 6C ). We were unable to determine the effect of DFO on the ability of Gamide to stimulate inositol phosphate production in IMGE cells because the maximum response to gastrins was only 110% of control in this cell line (Pannequin et al. 2004) . Our present data with DFO confirm that the binding of ferric ions to Glu7, Glu8 and Glu9 of Gamide is not essential for CCK-2 receptor binding or biological activity.
This conclusion at first sight appears to conflict with our earlier report that DFO reduced Gamide-stimulated proliferation of the gastric cell line IMGE by 60% (Pannequin et al. 2002) . One possible explanation for this apparent discrepancy is that the proliferative response to Gamide was measured over a 72 h period, whereas the inositol phosphate assay used to assess the effect of DFO in the current report was for 1 h only. Kicic and coworkers (2001) have previously shown that the inhibition of cellular ferric ion uptake by DFO is time dependent, with little or no inhibition after 2 h, and significant inhibition after 24 h. We therefore postulate that proliferation involves a rate-limiting ferric ion-dependent step, such as cellular ferric ion uptake, which is not controlled by the CCK-2 receptor, and that this step is inhibited only after prolonged incubation with DFO. Further work to resolve this apparent discrepancy is underway.
In conclusion, the binding of ferric ions by Gamide has been investigated for the first time. Glu7, Glu8 and Glu9 have been shown to act as ligands at the two ferric ion binding sites. Investigation of the activity of Gamide mutants in proliferation and inositol phosphate assays revealed that Glu7, Glu8 and Glu9 are not essential for biological activity. Furthermore the observation that the iron chelator DFO did not inhibit binding of Gamide to the CCK-2 receptor or Gamide-stimulated inositol phosphate production confirmed that ferric ion binding is not essential for the biological activity of Gamide. The absence of any requirement for ferric ion binding to the -(Glu) 5 -sequence for Gamide activity is in direct contrast to Ggly, the glutamates of which are essential for activity. The present work thus confirms that the mechanisms of action of the glycine-extended and amidated forms of the peptide hormone gastrin are distinct, and demonstrates for the first time a selective dependence of the glycine-extended form on the presence of ferric ions for bioactivity. Our findings reinforce the concept that Ggly should be considered a distinct bioactive end product rather than the precursor of the mature amidated form .
These observations open several avenues for future investigation. As described previously the complex between ferric ions and gastrins may play a role in the uptake of ferric ions from the lumen of the gastrointestinal tract (Baldwin et al. 2001a) . Alternatively formation of the complex between gastrins and ferric ions may increase the stability of gastrins in vivo, and hence modulate the duration of the biological response to gastrins. Furthermore the contrasting requirements for ferric ion binding between Ggly and Gamide are consistent with the hypothesis that the Ggly receptor and the CCK-2 receptor have quite different structures. Appropriate ferric ion chelation and competition strategies could therefore be developed for the selective inhibition of the biological activity of Ggly. For example, our observations with the ferric ion chelator DFO suggest that treatment of animals with DFO would abolish Ggly-, and reduce Gamide-, dependent proliferation in the colonic mucosa, but would not change Gamide-dependent acid secretion. Finally, two general principles emerge from the present work. First, amidation may dramatically alter both the site of action of a peptide and the nature of its physiological effect. Secondly, the differences in receptor binding between amidated and non-amidated peptides could be utilised to develop targeted antagonists.
